On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

VPS37A

VPS37A subunit of ESCRT-I

Chromosome 8p22 HGNC:24928 Tier C
VPS37A 8p22 p arm q arm 8

VPS37A is located on the short (p) arm of chromosome 8, at band 8p22. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 8 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

VPS37A is located on chromosome 8 at position 8p22 and encodes a subunit of the endosomal sorting complex required for transport-I (ESCRT-I). The ESCRT system comprises four main complexes (ESCRT-0, -I, -II, and -III) that work sequentially to sort membrane proteins into vesicles for degradation inside cellular compartments called endosomes. VPS37A functions as one of four core components of ESCRT-I, alongside TSG101, VPS28, and VPS37B or VPS37C. This sorting machinery is fundamental to numerous cellular processes, including receptor down-regulation, viral budding, and cytokinesis. Without proper ESCRT function, cells cannot efficiently remove damaged or obsolete proteins from their membranes, potentially disrupting normal cellular signalling and homeostasis.

What the gene does

The VPS37A protein participates in the endosomal sorting pathway by helping to recognise and capture membrane proteins marked for degradation. When cell-surface receptors are activated by signals such as growth factors, they are typically internalised into endosomes and either recycled back to the surface or directed toward lysosomes for breakdown. The ESCRT-I complex, containing VPS37A, binds to ubiquitinated cargo proteins and helps coordinate their packaging into intraluminal vesicles within multivesicular bodies. This process ensures that signalling receptors are appropriately down-regulated after activation, preventing excessive cellular responses. The ESCRT machinery also plays essential roles during cell division, where it facilitates the final membrane severing step that separates daughter cells. Additionally, enveloped viruses such as HIV-1 exploit the ESCRT pathway during budding from infected cells, recruiting ESCRT components to assist in viral particle release. Through these diverse functions, VPS37A contributes to cellular quality control and membrane dynamics.

Video: Genetics 101

Chromosome location

VPS37A is positioned on the short arm of chromosome 8 at cytogenetic band 8p22. This chromosomal region contains numerous genes involved in cellular regulation and development. The specific exon structure and genomic span of VPS37A have been catalogued in genome databases, though detailed transcript architecture may vary between isoforms. The 8p22 region has been studied in the context of chromosomal rearrangements and copy number variations, though VPS37A itself is not prominently featured in clinical genomic medicine panels at present.

Protein structure

Domain architecture has not been experimentally characterised in detail for this protein. While VPS37A is known to interact with other ESCRT-I subunits through specific binding interfaces, the precise structural domains mediating these interactions have not been fully annotated in structural databases. The protein contributes to ESCRT-I complex assembly and stability, working in concert with TSG101, which provides the main ubiquitin-binding capability, and VPS28, which bridges to downstream ESCRT-II components.

Domain map · 397 amino acids
VPS37 C-terminal (308-397)VPS37 C-terminal308-3971~199397
Domain - independent functional unit
🧬 Explore 3D structure on AlphaFold
UniProt:Q8NEZ2Length:397 aaStructure:AlphaFold

Key variants

Genetic variants in VPS37A have been identified through population sequencing efforts and variant databases such as ClinVar. Because VPS37A has not been definitively linked to a Mendelian disorder, most variants catalogued in the gene are classified as variants of uncertain significance or are population polymorphisms with no established clinical consequence. Research into ESCRT pathway dysfunction continues to explore potential associations between rare variants in ESCRT components and cellular phenotypes, though specific disease outcomes attributable to VPS37A variation remain under investigation.

No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.

Associated conditions

Currently, VPS37A is not recognised as a gene with definitive associations to inherited human diseases in major clinical databases. While the ESCRT pathway as a whole is essential for cellular viability, and disruption of certain ESCRT components can cause severe developmental or neurological phenotypes, VPS37A-specific pathogenic variants have not been conclusively linked to a clinical syndrome. This may reflect functional redundancy among VPS37 family members (VPS37A, VPS37B, VPS37C, and VPS37D) or incomplete understanding of rare variant effects. Ongoing research in cellular trafficking disorders may reveal associations in the future.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

UK clinical status

Frequently asked questions

What does the VPS37A protein do in cells?

VPS37A is a component of the ESCRT-I complex, which sorts membrane proteins into vesicles for degradation. This process helps cells regulate surface receptors, complete cell division, and maintain membrane organisation.

Is VPS37A associated with any inherited conditions?

At present, VPS37A is not definitively linked to a recognised Mendelian disorder. While the ESCRT pathway is essential for cellular function, VPS37A-specific disease associations have not been conclusively established in clinical literature.

Are there other genes with similar functions to VPS37A?

Yes, VPS37A belongs to a family that includes VPS37B, VPS37C, and VPS37D, which can perform overlapping roles in ESCRT-I assembly. Related genes such as TSG101 and VPS28 also contribute to the same cellular trafficking pathway.

Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 17 April 2026. Content compiled from HGNC · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .